Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

BACKGROUND: Bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ) is an adverse effect of bisphosphonate treatment with varying reported incidence rates. METHODS: In two neighboring German cities, prevalence and additional factors of the development of BP-ONJ in multiple myeloma patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Christian, Al-Nawas, Bilal, Frickhofen, Norbert, Gamm, Heinold, Beck, Joachim, Reinsch, Laura, Blum, Christina, Grötz, Knut A, Wagner, Wilfried
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912876/
https://www.ncbi.nlm.nih.gov/pubmed/20615236
http://dx.doi.org/10.1186/1746-160X-6-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912876/
https://www.ncbi.nlm.nih.gov/pubmed/20615236
http://dx.doi.org/10.1186/1746-160X-6-11

Ejemplares similares